Clinical Trial

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly detect and manage high blood sugar in pregnant women, early in pregnancy. The main questions it aims to answer are: (1) any problems for the baby, such as being too large for their age, shoulder injuries (like broken bones), high bilirubin levels needing light treatment, low blood sugar, or needing to stay in the NICU; (2) any high blood pressure issues for the mother during pregnancy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-25; most recent amendment 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2025-11-11
Trial Details
NCT Number NCT06957028
Lead Sponsor Jaeb Center for Health Research
Collaborators: The Leona M. and Harry B. Helmsley Charitable Trust, DexCom, Inc., Abbott
Conditions Gestational Diabetes Mellitus in Pregnancy
Enrollment 6,000 participants
Start Date 2025-05-27
Primary Completion 2027-11-27 (estimated)
Study Completion 2027-11-27 (estimated)
Updated on ClinicalTrials.gov 2025-12-23